Melasma in men:A clinical, aetiological and histological study
GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and lixisenatide (Lyxumia)
The initial use is one capsule per day, then regular use is one capsule two times per day, and experienced user use is two capsules two times per day. When testing out the capsule, Pete described it as follows: No taste, it is made of hypromellose instead of gelatin
How GHK-Cu actually works at the hair follicle level Whether GHK-Cu genuinely affects DHT or 5-alpha reductase What the current clinical evidence shows for pattern hair loss Topical and injectable dosage protocols used in research and practice How GHK-Cu compares to minoxidil and finasteride Realistic timelines and results from consistent use Side effects, contraindications, and stacking strategies GHK-Cu is a tripeptide composed of three amino acids (glycine, histidine, and lysine) bound to a copper ion
This peptide has demonstrated protective effects in preclinical models of heart failure, neurodegenerative disease, and agerelated muscle atrophy, and received FDA accelerated approval in 2025 as the first treatment for Barth syndrome [3]
Dulaglutide is supported by randomized evidence from REWIND [26] and AWARD-7 [5], demonstrating reductions in composite kidney outcomes and sustained preservation of kidney function, including in patients with moderate-to-severe CKD